PIDILITINDBSEPIDILITE INDUSTRIES LTD· Chemicals - SpecialityHighNeutral
Announced Wed, 28 Oct, 2026 · 19:04 IST

Q2 FY27 revenue up 21%, but profit growth trails sales

Revenue Growth 20pctEbitda Margin CompressionExceptional ItemResults View source PDFExplain this filing

PIDILITIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Consolidated Q2 FY27 revenue rose 20.9% to Rs 4,297.59 crore, but PAT attributable to shareholders rose 6.1% to Rs 614.53 crore, showing margin pressure. Standalone PAT rose 10.4% to Rs 647.00 crore. H1 revenue rose 21.1% to Rs 8,849.14 crore and PAT rose 18.8% to Rs 1,486.94 crore, including a Rs 14.41 crore one-off gain. H1 operating cash flow was Rs 1,098.11 crore. Auditors gave an unmodified review.

Likely market impact

Strong sales growth is positive, but narrower margins and slower profit growth may temper the stock reaction.